XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Out-license Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2021
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
License, Collaboration and Manufacturing Agreements [Line Items]            
License and collaboration revenue         $ 687 $ 63,573
Deferred revenue, December 31, 2022 $ 115,395 $ 85,000     115,395 85,000
Less: deferred revenue - current portion 77,833       77,833  
Deferred revenue - long-term, December 31, 2023 37,562 77,000     37,562 77,000
Deferred revenue, revenue recognized         5,000  
Bayer Manufacturing Agreement            
License, Collaboration and Manufacturing Agreements [Line Items]            
License and collaboration revenue       $ 61,800 0  
Deferred revenue, December 31, 2022 0 0     0 0
Receivable for early contract       4,200    
Hcrx Agreement [Member]            
License, Collaboration and Manufacturing Agreements [Line Items]            
Proceeds from sale of future royalties, gross         $ 31,000 31,000
Minimum Cash Repayment         185.00%  
Maximum Cash Repayment         250.00%  
Bayer Agreements            
License, Collaboration and Manufacturing Agreements [Line Items]            
License and collaboration revenue           61,800
Pierre Fabre Commercialization Agreement            
License, Collaboration and Manufacturing Agreements [Line Items]            
Upfront cash payment received $ 20,000   $ 45,000      
Royalty eligible to receive term after first commercial sale 12 years   12 years      
License and collaboration revenue           1,800
Development or sales-based milestone payments earned or received   40,000   $ 30,000    
Determined upfront payment constituted entire consideration included in transaction price     $ 45,000      
Milestone payments   $ 40,000       40,000
Pierre Fabre Commercialization Agreement | Maximum            
License, Collaboration and Manufacturing Agreements [Line Items]            
Aggregate milestone payments entitle to receive upon achieving certain regulatory and commercial milestones $ 620,000   $ 308,000   $ 620,000  
A&R Commercialization Agreement [Member]            
License, Collaboration and Manufacturing Agreements [Line Items]            
License and collaboration revenue         700 $ 1,800
Additional Upfront Payment Included inTransaction Price $ 20,000       $ 20,000